Cargando…
Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not...
Autores principales: | Shoji, Kensuke, Asai, Yusuke, Akiyama, Takayuki, Tsuzuki, Shinya, Matsunaga, Nobuaki, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Miyairi, Isao, Ohmagari, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259089/ https://www.ncbi.nlm.nih.gov/pubmed/37315843 http://dx.doi.org/10.1016/j.jiac.2023.06.006 |
Ejemplares similares
-
Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023) -
Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022) -
Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022) -
Impact of regional heterogeneity on the severity of COVID-19
por: Tsuzuki, Shinya, et al.
Publicado: (2022) -
Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023)